Specific therapy in Parkinson's disease.
出版信息
Med J Aust. 1970 Oct 3;2(14):612-3. doi: 10.5694/j.1326-5377.1970.tb50233.x.
Abstract
摘要
相似文献
1
Specific therapy in Parkinson's disease.
Med J Aust. 1970 Oct 3;2(14):612-3. doi: 10.5694/j.1326-5377.1970.tb50233.x.
2
Adverse reactions during treatment of Parkinson's disease with levodopa.
JAMA. 1971 Jun 21;216(12):1979-83.
3
Combined treatment of parkinsonism with L-dopa and amantadine.
Lancet. 1970 Aug 22;2(7669):383-5. doi: 10.1016/s0140-6736(70)90002-4.
4
[L-dopa and Parkinson's disease].
Union Med Can. 1970 Dec;99(12):2195-7.
5
L-dopa. II.左旋多巴。二。
Br Med J. 1970 Nov 28;4(5734):541-2.
6
L-dopa therapy in Parkinson's disease.
Va Med Mon (1918). 1971 May;98(5):242-8.
7
A second report on Levodopa.
Med Lett Drugs Ther. 1969 Sep 5;11(18):73-5.
8
Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.
Z Neurol. 1972;202(3):197-208. doi: 10.1007/BF00316221.
9
L-Dopa in the treatment of Parkinson's disease.左旋多巴治疗帕金森病。
Med J Aust. 1970 Oct 3;2(14):632-4. doi: 10.5694/j.1326-5377.1970.tb50240.x.
10
L-dopa in idiopathic parkinsonism.
Lancet. 1969 Nov 8;2(7628):973-6. doi: 10.1016/s0140-6736(69)90536-4.
Zotero 插件